Dr. Wosiski-Kuhn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Wake Forest School of Medicine
Winston Salem, NC 27101
Education & Training
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2017
Publications & Presentations
PubMed
- 15 citationsInterleukin 6 (IL6) level is a biomarker for functional disease progression within IL6R358Ala variant groups in amyotrophic lateral sclerosis patients.Marlena Wosiski-Kuhn, James Caress, Michael S. Cartwright, Gregory A. Hawkins, Carol Milligan
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2021-04-03 - 18 citationsIL6 receptor358Ala variant and trans-signaling are disease modifiers in amyotrophic lateral sclerosis.Marlena Wosiski-Kuhn, Mac B. Robinson, Jane L. Strupe, Phonepasong Arounleut, Matthew Martin
Neurology(R) Neuroimmunology & Neuroinflammation. 2019-10-14 - 13 citationsA pilot study of neuromuscular ultrasound as a biomarker for amyotrophic lateral sclerosis.Sapna Pathak, James B. Caress, Marlena Wosiski-Kuhn, Carol Milligan, Delaney Williams
Muscle & Nerve. 2019-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
